ATG16L1 and inflammatory bowel disease: At the genetic level, variants of NOD2 and ATG16L1, the main risk genes for IBD, cause defects in the innate immunity of the intestine, resulting in alterations in the structure of intestinal microbes and impaired protective function of commensal bacteria, thereby inducing the development of IBD (Chu et al., 2016).